Guangzhou Red Cross Hospital Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00548223
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Guagnzhou Red Cross Hospital | Guangzhou Red Cross Hospital | Liang Bing

Active Ingredients

Drugs in Phase 4 Trials (1)

deng zhan sheng mai (1 trial)

Drugs in Phase 3 Trials (1)

borneol (1 trial)

Drugs in Phase 1 Trials (1)

dobutamine (dobutrex) (1 trial)

Drugs in Other Trials (1)

nitroglycerin (transderm-nitro) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4